News

A group of type 1 antibodies recently made available by Bio-Rad Laboratories are intended to prevent the drug evolcumab from attaching to its target, human proprotein convertase subtilisin/kexin type 9. (PCSK9). These recombinant, sequence-defined antibodies are meant to create...

On September 1, 2022, Novo Nordisk and Forma Therapeutics revealed that Novo Nordisk would buy Forma Therapeutics for for $1.1 billion. With the purchase of Forma, Novo Nordisk now has access to the company's inventory of sickle cell disease...

By demonstrating a massive survival benefit, Keytruda's Keynote-189 study precipitated a turning point in the development of lung cancer medications. Merck & Co. is now providing a five-year review of the data that rendered the PD-1 inhibitor the norm...

The treatment for paediatric patients with severe malaria is being evaluated through research. The first patient has been enrolled in the SEVUSMART study, according to a statement from Modus Therapeutics, a firm that creates therapies for individuals who have significant unmet...

Leg ulcers are common and often painful wounds that can form on the leg. They can be caused by a number of factors, including circulation problems, injury, or infection. Treatment for leg ulcers typically involves dressings and antibiotics, but...

For intravenous infusion in paediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD), a rare genetic disorder that results in early death, the U.S. Food and Drug Administration has approved Xenpozyme (Olipudase alfa). Xenpozyme is the first drug that...

Yes! We all should be. This terminal illness is caused by a virus located in tropical Africa. Despite its name, “Monkeypox,” monkeypox is spread by rodents such as rats, squirrels, and mice rather than ill monkeys. The virus is...